AMUSX | UGSFX | AMUSX / UGSFX | |
Total Expense Ratio | 0.66 | 0.69 | 96% |
Annual Report Gross Expense Ratio | 0.70 | 0.73 | 96% |
Fund Existence | 40 years | 24 years | - |
Gain YTD | 3.978 | 4.039 | 98% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 22.9B | 22.9B | 100% |
Annual Yield % from dividends | 4.06 | 4.02 | 101% |
Returns for 1 year | 5.67 | 5.63 | 101% |
Returns for 3 years | 2.54 | 2.55 | 100% |
Returns for 5 years | -8.20 | -8.30 | 99% |
Returns for 10 years | 4.68 | 4.57 | 102% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RSPS | 30.60 | 0.08 | +0.25% |
Invesco S&P 500® Eql Wt Cnsm Stapl ETF | |||
CXH | 7.62 | 0.01 | +0.13% |
MFS Investment Grade Municipal Trust | |||
CNCR | 9.02 | N/A | N/A |
Range Cancer Therapeutics ETF | |||
ETH | 24.26 | -0.30 | -1.22% |
Grayscale Ethereum Mini Trust ETF | |||
YINN | 39.39 | -1.35 | -3.31% |
Direxion Daily FTSE China Bull 3X ETF |